journal article·2018-10-31

Simultaneous determination of AM80 (tamibarotene) and WJD-A-1 in rat plasma by ultra high-performance liquid chromatography–tandem mass spectrometry and its application to a pharmacokinetic study

Ping Leng, Zhao Yang, Baohua Ma, Jing Li, Jialin Sun, Yiming Xie, Yong Sun

Publisher page

Abstract

A compound (WJD-A-1) was previously reported as a candidate prodrug of Am80 (tamibarotene), which was approved in Japan in 2005 as a therapeutic agent for recurrent refractory acute promyelocytic leukaemia. A rapid, selective and sensitive ultra high-performance liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS) method was developed for the first time to simultaneously determine WJD-A-1 and its major phase-I metabolites AM80 in rat plasma. After a simple sample preparation procedure by protein precipitation with methanol and acetonitrile, WJD-A-1, AM80 and the internal standard were chromatographed on an ACQUITY UPLCTM BEH C18 column. The mobile phase consisted of methanol–0.1% formic acid (80:20, v/v) and the flow rate was 0.20 mL/min. The detection was performed on a triple quadrupole tandem mass spectrometer by multiple reaction monitoring (MRM) mode via electrospray ionization (ESI) source. Each plasma sample was chromatographed within 2.6 min. The linear calibration curves for WJD-A-1 and the AM80 were obtained in the concentration range of 5.40–5.40 × 103 and 5.08–5.08 × 103 ng/mL, respectively (r ≥ 0.99). The intra- and inter-day precision (relative standard deviation, RSD) values were less than 8% and the accuracy (relative error, RE) was within ±6.8%, determined from quality control (QC) samples for the analytes. The method herein described was fully validated and successfully applied to pharmacokinetic study of WJD-A-1 following an intravenous administration of 300 μg/kg WJD-A-1 to rats.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrochemical sensors and biosensors · Molecular Sensors and Ion Detection · Analytical Chemistry and Sensors

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics, School of Pharmacy

, Qingdao University

Department of Pharmacy, Affiliated Hospital of Qingdao University

Qingdao Institute for Food and Drug Control

Department of Pharmacy, Qingdao Central Hospital

Funding

National Natural Science Foundation of China · Shandong Provincial Natural Science Foundation

References (14)

Show source-provided references
1. 10.1021/jm00119a02110.1021/jm00119a021 ↗
2. 10.1038/sj.leu.240303110.1038/sj.leu.2403031 ↗
3. 10.1358/dot.2007.43.8.107261510.1358/dot.2007.43.8.1072615 ↗
4. 10.1111/cbdd.1277810.1111/cbdd.12778 ↗
5. Golchin K, Golchin J, Ghaderi S, et al. Gold nanoparticles applications: from artificial enzyme till drug delivery. Artif Cells Nanomed Biotechnol. 2017;45:250–254.
6. 10.1080/21691401.2017.131326810.1080/21691401.2017.1313268 ↗
7. Asadi N, Davaran S, Panahi Y, et al. Application of nanostructured drug delivery systems in immunotherapy of cancer: a review. Artif Cells Nanomed Biotechnol. 2016;44:18–23.
8. Yu M, Han S, Kou Z, et al. Lipid nanoparticle-based co-delivery of epirubicin and BCL-2 siRNA for enhanced intracellular drug release and reversing multidrug resistance. Artif Cells Nanomed Biotechnol. 2017;45:323–332.
9. Haghiralsadat F, Amoabediny G, Helder MN, et al. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery. Artif Cells Nanomed Biotechnol. 2017;45:169–177.
10. 10.1081/IAS-10010470710.1081/IAS-100104707 ↗
11. 10.1016/j.jchromb.2007.05.01610.1016/j.jchromb.2007.05.016 ↗
12. US Food and Drug Administration Center for Drug Evaluation and Research. Guidance for industry: bioanalytical method validation; 2001. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInfo-rmation/Guidances/UCM070107.pdf
13. 10.3109/21691401.2014.88340210.3109/21691401.2014.883402 ↗
14. 10.1016/j.aca.2009.10.00410.1016/j.aca.2009.10.004 ↗